糖尿病护理设备市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Diabetes Care Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年11月05日 | 出版商:

Global Market Insights Inc. | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球糖尿病护理设备市场达到 451 亿美元，预计 2024 年至 2032 年复合年增长率为 11.4%。连续血糖监测仪(CGM)、胰岛素帮浦、智慧型胰岛素笔、注射器和刺血针。

市场分为胰岛素输送设备、血糖监测设备、注射器和其他工具。血糖监测设备，包括自我监测血糖仪、连续血糖监测仪、试纸和刺血针，是最大的细分市场。这些设备在 2023 年将占据重要份额，预计复合年增长率为 11.6%。这些设备对于糖尿病患者至关重要，使他们能够追踪血糖水平并就饮食、运动和胰岛素剂量做出明智的决定。持续监测有助于预防低血糖和高血糖，让使用者更好地控制血糖水平，并增强有效管理糖尿病的能力。

该市场还按最终用户类别进行细分，包括医院、门诊手术中心、诊断中心、家庭护理机构等。医院是最大的最终用户部分，占据了显着的市场份额。这些医疗机构是糖尿病照护不可或缺的一部分，提供包括诊断、治疗和持续监测在内的全面服务。医院需要各种糖尿病护理设备，包括血糖仪、胰岛素帮浦、CGM 和胰岛素笔，这些设备已嵌入患者护理方案中以支援有效的糖尿病管理。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	451 亿美元
预测值	1186 亿美元
复合年增长率	11.4%

北美糖尿病护理设备市场以美国为主导，该国在 2023 年的收入最高。美国强劲的医疗保健支出在推动这些设备的采用方面发挥关键作用，因为它使人们能够获得最先进的治疗选择。此外，有利的监管环境支持新糖尿病护理技术的开发和批准，促进市场内的创新和成长。

总体而言，在糖尿病盛行率不断上升、有效管理解决方案意识不断增强以及医疗技术不断进步的推动下，糖尿病护理设备市场有望显着增长。

产业生态系统分析
产业影响力
- 成长动力
  - 全球糖尿病盛行率不断上升
  - 糖尿病护理设备不断进步的技术
  - 增加公共和私人组织对糖尿病护理的投资
- 产业陷阱与挑战
  - 糖尿病照护设备成本高昂
  - 严格的监管框架
成长潜力分析
监管环境
技术景观
报销场景
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
血糖监测设备
- 自我监测血糖仪
- 连续血糖监测仪
- 测试条
- 柳叶刀
胰岛素输送装置
- 胰岛素帮浦
  - 管式帮浦
  - 无内胎帮浦
- 钢笔
  - 可重复使用的
  - 一次性的
- 笔针
  - 标准
  - 安全
- 注射器
- 其他胰岛素输送装置

第 6 章：市场估计与预测：依最终用途，2021 - 2032 年

主要趋势
医院
门诊手术中心
诊断中心
居家护理
其他最终用户

第 7 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 法国
- 英国
- 义大利
- 西班牙
- 荷兰
- 瑞典
- 比利时
- 丹麦
- 芬兰
- 挪威
- 立陶宛
- 拉脱维亚
- 爱沙尼亚
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 智利
- 秘鲁
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 土耳其
- 埃及
- 以色列
- 科威特
- 卡达

第 8 章：公司简介

Abbott Laboratories
ARKRAY
Ascensia Diabetes Care Holding
B. Braun Melsungen
Becton, Dickinson and Company
Bionime Corporation
DarioHealth Corp.
Dexcom
Dr. Reddy's Laboratories
Eli Lilly and Company
F. Hoffmann-La Roche
Insulet Corporation
Medtronic
Nova Biomedical
Novo Nordisk
Pendiq
Platinum Equity Advisors
Sanofi
Sinocare
Tandem Diabetes Care
Ypsomed Holding

简介目录

Product Code: 3250

The Global Diabetes Care Devices Market reached USD 45.1 billion in 2023 and is projected to grow at a CAGR of 11.4% from 2024 to 2032. This market includes a wide range of devices designed to support individuals in managing their blood sugar levels and insulin therapy effectively, such as blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, smart insulin pens, syringes, and lancets.

The market is categorized into insulin delivery devices, blood glucose monitoring devices, syringes, and other tools. Blood glucose monitoring devices, which include self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets, represent the largest segment. These devices accounted for a significant share in 2023 and are expected to grow at 11.6% CAGR. These devices are essential for people with diabetes, allowing them to track their blood sugar levels and make informed decisions regarding diet, exercise, and insulin doses. Continuous monitoring helps prevent hypoglycemia and hyperglycemia, giving users greater control over their glucose levels and enhancing their ability to manage diabetes effectively.

The market is also segmented by end-user categories, which include hospitals, ambulatory surgical centers, diagnostic centers, homecare settings, and others. Hospitals are the largest end-user segment, accounting for a notable market share. These healthcare institutions are integral to diabetes care, offering comprehensive services that include diagnosis, treatment, and continuous monitoring. Hospitals require a diverse array of diabetes care devices, including glucose meters, insulin pumps, CGMs, and insulin pens, which are embedded into patient care protocols to support effective diabetes management.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$45.1 Billion
Forecast Value	$118.6 Billion
CAGR	11.4%

The North American diabetes care devices market is led by the U.S., which generated the highest revenue in 2023. The country's healthcare system is one of the most advanced globally, with significant investments in cutting-edge diabetes care technologies. The robust healthcare expenditure in the U.S. plays a key role in driving the adoption of these devices, as it enables access to state-of-the-art treatment options. Additionally, a favorable regulatory environment supports the development and approval of new diabetes care technologies, fostering innovation and growth within the market.

Overall, the diabetes care devices market is poised for significant growth, driven by the rising prevalence of diabetes, increasing awareness of effective management solutions, and the continued advancement of medical technology.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing prevalence of diabetes across the world
  - 3.2.1.2 Rising technological advancements in diabetes care devices
  - 3.2.1.3 Increasing investments by public and private organizations for diabetes care
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of diabetes care devices
  - 3.2.2.2 Rigorous regulatory framework
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Blood glucose monitoring devices
- 5.2.1 Self-monitoring blood glucose meters
- 5.2.2 Continuous glucose monitors
- 5.2.3 Testing strips
- 5.2.4 Lancets
5.3 Insulin delivery devices
- 5.3.1 Insulin pumps
  - 5.3.1.1 Tubed pumps
  - 5.3.1.2 Tubeless pumps
- 5.3.2 Pens
  - 5.3.2.1 Reusable
  - 5.3.2.2 Disposable
- 5.3.3 Pen needles
  - 5.3.3.1 Standard
  - 5.3.3.2 Safety
- 5.3.4 Syringes
- 5.3.5 Other insulin delivery devices

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospital
6.3 Ambulatory surgical centres
6.4 Diagnostic centres
6.5 Homecare
6.6 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 France
- 7.3.3 UK
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Netherlands
- 7.3.7 Sweden
- 7.3.8 Belgium
- 7.3.9 Denmark
- 7.3.10 Finland
- 7.3.11 Norway
- 7.3.12 Lithuania
- 7.3.13 Latvia
- 7.3.14 Estonia
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Colombia
- 7.5.5 Chile
- 7.5.6 Peru
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Turkey
- 7.6.5 Egypt
- 7.6.6 Israel
- 7.6.7 Kuwait
- 7.6.8 Qatar